Mostrar el registro sencillo del ítem

dc.contributor.authorEslava Alcón, Sara 
dc.contributor.authorExtremera-García, MJ
dc.contributor.authorGonzález-Rovira, A
dc.contributor.authorRosal-Vela, A
dc.contributor.authorRojas-Torres, M
dc.contributor.authorBeltran-Camacho, L
dc.contributor.authorSanchez-Gomar, I
dc.contributor.authorJiménez-Palomares, M
dc.contributor.authorAlonso-Piñero, JA
dc.contributor.authorConejero, R
dc.contributor.authorDoiz, E
dc.contributor.authorOlarte, J
dc.contributor.authorFoncubierta-Fernández, A
dc.contributor.authorLozano, E
dc.contributor.authorGarcía-Cozar, FJ
dc.contributor.authorRodríguez-Piñero, M
dc.contributor.authorAlvarez-Llamas, G
dc.contributor.authorDuran-Ruiz, MC
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2025-01-20T19:21:54Z
dc.date.available2025-01-20T19:21:54Z
dc.date.issued2020-06-15
dc.identifier.issn1874-3919
dc.identifier.urihttp://hdl.handle.net/10498/34592
dc.description.abstractAtherosclerosis remains the leading cause of ischemic syndromes such as myocardial infarction or brain stroke, mainly promoted by plaque rupture and subsequent arterial blockade. Identification of vulnerable or high-risk plaques constitutes a major challenge, being necessary to identify patients at risk of occlusive events in order to provide them with appropriate therapies. Clinical imaging tools have allowed the identification of certain structural indicators of prone-rupture plaques, including a necrotic lipidic core, intimal and adventitial inflammation, extracellular matrix dysregulation, and smooth muscle cell depletion and micro-calcification. Additionally, alternative approaches focused on identifying molecular biomarkers of atherosclerosis have also been applied. Among them, proteomics has provided numerous protein markers currently investigated in clinical practice. In this regard, it is quite uncertain that a single molecule can describe plaque rupture, due to the complexity of the process itself. Therefore, it should be more accurate to consider a set of markers to define plaques at risk. Herein, we propose a selection of 76 proteins, from classical inflammatory to recently related markers, all of them identified in at least two proteomic studies analyzing unstable atherosclerotic plaques. Such panel could be used as a prognostic signature of plaque instability.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherELSEVIERes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceJournal of Proteomics, Volume 221, 2020, 103757, ISSN 1874-3919, https://doi.org/10.1016/j.jprot.2020.103757.es_ES
dc.subjectVulnerable plaqueses_ES
dc.subjectBiomarkerses_ES
dc.subjectSecretomees_ES
dc.subjectProteomicses_ES
dc.subjectAtherosclerosises_ES
dc.titleMolecular signatures of atherosclerotic plaques: An up-dated panel of protein related markerses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1016/j.jprot.2020.103757.
dc.relation.projectIDThis work was supported by the Institute of Health Carlos III, ISCIII (PI16-00784, P16-01334), and co-supported by FEDER grants: PRB3 [IPT1/0019 ISCIIIS-GEFI/ERDF] and the “Programa Operativo de Andalucia FEDER, Iniciativa Territorial Integrada ITI 2014-2020", Consejeria de Salud, Junta de Andalucia (PI0026-2017)es_ES
dc.type.hasVersionSMURes_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Esta obra está bajo una Licencia Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Internacional